Skip to content

Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug

The drugmaker said that its step-down subsidiary company Aurolife Pharma has received USFDA#39;s approval to manufacture and market Diclofenac Sodium Topical Solution USP.

Read More

​ The drugmaker said that its step-down subsidiary company Aurolife Pharma has received USFDA#39;s approval to manufacture and market Diclofenac Sodium Topical Solution USP. The drugmaker said that its step-down subsidiary company Aurolife Pharma has received USFDA#39;s approval to manufacture and market Diclofenac Sodium Topical Solution USP.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish